The Impact Of mHealth On Real-World Data Collection
Source: ERT
As mHealth continues to grow and apps expand into different areas, the opportunities for health improvements also grow, as do complexities. This article ─ including comments from ERT’s Dr. Chris Watson and Gavin Birchnall ─ reviews how pharmaceutical companies will need to carefully balance mHealth innovation with a clear understanding of the evolving regulatory guidelines. This article reviews the huge potential of mobile health, or mHealth not only for patients, caregivers, and physicians, but also for pharmaceutical companies.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more